RYCARMA

Serial Number 99006283
641

Registration Progress

Application Filed
Jan 17, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Sep 30, 2025 80 days

Trademark Image

RYCARMA

Basic Information

Serial Number
99006283
Deadline
September 30, 2025
Description
Respond to Non-Final Office Action
Filing Date
January 17, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Jun 30, 2025
Application
Pending
Classes
005 042

Rights Holder

RyCarma Therapeutics, Inc.

03
Address
200 Clarendon Street, 22nd Floor
Boston, MA 02116

Ownership History

RyCarma Therapeutics, Inc.

Original Applicant
03
Boston, MA

Legal Representation

Attorney
Matthew D. Asbell

USPTO Deadlines

Next Deadline
80 days remaining
Non-Final Action E-Mailed
Due Date
September 30, 2025
Extension Available
Until December 30, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

7 events
Date Code Type Description
Jun 30, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 30, 2025 CNRT R NON-FINAL ACTION WRITTEN
Jun 30, 2025 GNRT F NON-FINAL ACTION E-MAILED
Jun 26, 2025 DOCK D ASSIGNED TO EXAMINER
Jun 20, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
Jan 17, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for that restoring normal intracellular calcium regulation; Chemical preparations for pharmaceutical or medical purposes, namely, for restoring normal intracellular calcium regulation; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders and diseases, skeletal muscle disorders and diseases, muscle fatigue, cognitive disorders and bone disorders; a full line of medicinal and pharmaceutical preparations; chemical preparations for pharmaceutical or medical purposes, namely, for cardiovascular disorders and diseases, skeletal muscle disorders and diseases, muscle fatigue, cognitive disorders and bone disorders
Class 042
Pharmaceutical research and development

Classification

International Classes
005 042